🔎 Trials Near Me

መነሻ › በርኪት ሊምፎማ › Ohio › Cincinnati

በCincinnati፣ OH ለበርኪት ሊምፎማ የሚደረጉ ክሊኒካዊ ጥናቶች

ለበርኪት ሊምፎማ የሚደረጉ 12 ጥናቶች በCincinnati እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
366 Days – 46 Years · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
  • University of Cincinnati Cancer Center-West Chester, West Chester · 15 ማይል ርቀት
እድሜ ከ18 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT03150693

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Cincinnati Children's Hospital Medical Center, Cincinnati
እድሜ ከ0 እስከ 38 · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06131801

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
  • University of Cincinnati Cancer Center-West Chester, West Chester · 15 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT03739814

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
365 Days · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06317662

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University of Cincinnati Medical Center, Cincinnati
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT07648264

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Cincinnati Children's Hospital Medical Center (Data Collection Only), Cincinnati
እድሜ 1 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07223021

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
እድሜ ከ1 እስከ 30 · ሁሉም ጾታዎች · የተሻሻለው በ1 ሴፕቴ 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Cincinnati Children's Hospital Medical Center, Cincinnati
365 Days – 25 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT03959085

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
እድሜ ከ7 እስከ 25 · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT05082519

Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Cincinnati Children's Hospital Medical Center, Cincinnati
እድሜ ከ1 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ18 ፌብሩ 2026 · NCT06863259

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Cincinnati, Cincinnati
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ኖቬም 2024 · NCT06034275

በሌሎች ከተሞች ለበርኪት ሊምፎማ የሚደረጉ ጥናቶች

በCincinnati ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።